Delivery Order SPE2DB20D1100-SPE2DB25FB5T9

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $4,203.37 firm fixed-price contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a medication, to support federal healthcare programs. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a $7,936.12 delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the provision of the pharmaceutical product VRAYLAR 1.5 MG CAPSULE 30S. The contract has a firm fixed price and an ultimate completion date of March 24, 2025. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of VRAYLAR 1.5 MG CAPSULE 30S. The $6,622.44 Firm Fixed Price contract has a completion date of September 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,668.83 firm fixed-price delivery order is for the supply of 4566660815 VRAYLAR 1.5 MG CAPSULE 30S, with a completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,867.32 firm fixed-price contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $2,939.46 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VRAYLAR 3 MG CAPSULE 30S, a medication, to support federal healthcare requirements. The contract has a completion date of February 14, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a key vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,065.14 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,033.29 Firm Fixed Price Delivery Order contract is for the provision of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,774.68 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.13 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB5T9
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,884.83 firm fixed-price contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 7/7/25, 12:52 PM